Newsroom
Category
May 19, 2026
Scientists at The University of Texas at San Antonio (UT San Antonio) are investigating a major immune system pathway that leads to the development of chronic pain and a drug that has the potential to stop the process in its tracks. Their study, published April 22 in Cell Reports, is the first of its kind to show a path toward the prevention of chronic pain.
May 7, 2026
The university is aware of a global Canvas service issue currently preventing users from logging into the application. The reported issue is impacting multiple educational institutions across the nation.
May 7, 2026
Claudia Suemoto, MD, PhD, from The University of Texas at San Antonio (UT San Antonio), has been awarded a $500,000 UT System Faculty STARs (Science and Technology Acquisition and Retention) award to tackle urgent research gaps in dementia. South Texas offers a distinct blend of genetic and environmental factors rarely explored in neurodegenerative research. […]
April 30, 2026
The University of Texas at San Antonio has been awarded a five-year, $44 million contract from the National Heart, Lung, and Blood Institute of the National Institutes of Health for a landmark study focused on persistent health challenges in the rural South.
April 27, 2026
UT Health San Antonio researchers awarded grant to study how circadian rhythm disruptions may contribute to Alzheimer’s
April 23, 2026
Written by: Claire Kowalick More than 70% of cancers — including breast, bladder, cervical and lung cancer — show evidence of mutations linked to a group of enzymes called apolipoprotein B mRNA-editing enzyme catalytic polypeptides, or APOBEC. “APOBEC mutagenesis is the second-largest source of mutation in cancer and, importantly, the largest one we can do […]
